Listed

Usana Health Sciences Inc

USNANYSECIK 896264HealthcareFiscal year ends Jan 3

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$223.3m, Q2 FY2026
Operating income−$20.0m, Q2 FY2026
Net income−$21.4m, Q2 FY2026
Usana Health Sciences Inc, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-30Q1 FY20242024-03-30Q2 FY20242024-06-29Q3 FY20242024-09-28Q4 FY20242024-12-28Q1 FY20252025-03-29Q2 FY20252025-06-28Q3 FY20252025-09-27Q4 FY20252026-01-03Q1 FY20262026-04-04Q2 FY20262026-07-04
Revenue$m213Revenue, Q3 FY2023, three months to 2023-09-30$213.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure221Revenue, Q4 FY2023, three months to 2023-12-30$221.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure228Revenue, Q1 FY2024, three months to 2024-03-30$227.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure213Revenue, Q2 FY2024, three months to 2024-06-29$212.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure200Revenue, Q3 FY2024, three months to 2024-09-28$200.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure214Revenue, Q4 FY2024, three months to 2024-12-28$213.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure250Revenue, Q1 FY2025, three months to 2025-03-29$249.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure236Revenue, Q2 FY2025, three months to 2025-06-28$235.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure214Revenue, Q3 FY2025, three months to 2025-09-27$213.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure226Revenue, Q4 FY2025, three months to 2026-01-03$226.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure250Revenue, Q1 FY2026, three months to 2026-04-04$250.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure223Revenue, Q2 FY2026, three months to 2026-07-04$223.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Cost of revenue$m42.5Cost of revenue, Q3 FY2023, three months to 2023-09-30$42.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure42.3Cost of revenue, Q4 FY2023, three months to 2023-12-30$42.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure43.1Cost of revenue, Q1 FY2024, three months to 2024-03-30$43.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure40.3Cost of revenue, Q2 FY2024, three months to 2024-06-29$40.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure39.3Cost of revenue, Q3 FY2024, three months to 2024-09-28$39.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure38.6Cost of revenue, Q4 FY2024, three months to 2024-12-28$38.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure52.4Cost of revenue, Q1 FY2025, three months to 2025-03-29$52.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure50.2Cost of revenue, Q2 FY2025, three months to 2025-06-28$50.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure48.8Cost of revenue, Q3 FY2025, three months to 2025-09-27$48.8m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure49.4Cost of revenue, Q4 FY2025, three months to 2026-01-03$49.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure59.4Cost of revenue, Q1 FY2026, three months to 2026-04-04$59.4m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure48.3Cost of revenue, Q2 FY2026, three months to 2026-07-04$48.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Gross profit$m171Gross profit, Q3 FY2023, three months to 2023-09-30$170.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure179Gross profit, Q4 FY2023, three months to 2023-12-30$178.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure185Gross profit, Q1 FY2024, three months to 2024-03-30$184.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure173Gross profit, Q2 FY2024, three months to 2024-06-29$172.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure161Gross profit, Q3 FY2024, three months to 2024-09-28$161.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure175Gross profit, Q4 FY2024, three months to 2024-12-28$175.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure197Gross profit, Q1 FY2025, three months to 2025-03-29$197.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure186Gross profit, Q2 FY2025, three months to 2025-06-28$185.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure165Gross profit, Q3 FY2025, three months to 2025-09-27$164.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure177Gross profit, Q4 FY2025, three months to 2026-01-03$176.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure191Gross profit, Q1 FY2026, three months to 2026-04-04$190.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure175Gross profit, Q2 FY2026, three months to 2026-07-04$174.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Selling, general and administrative$m63.3Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$63.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure58.7Selling, general and administrative, Q4 FY2023, three months to 2023-12-30$58.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure64.3Selling, general and administrative, Q1 FY2024, three months to 2024-03-30$64.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure64.3Selling, general and administrative, Q2 FY2024, three months to 2024-06-29$64.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure61.3Selling, general and administrative, Q3 FY2024, three months to 2024-09-28$61.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure73.3Selling, general and administrative, Q4 FY2024, three months to 2024-12-28$73.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure91.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-29$91.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure81.9Selling, general and administrative, Q2 FY2025, three months to 2025-06-28$81.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure85.9Selling, general and administrative, Q3 FY2025, three months to 2025-09-27$85.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure78.1Selling, general and administrative, Q4 FY2025, three months to 2026-01-03$78.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure88.3Selling, general and administrative, Q1 FY2026, three months to 2026-04-04$88.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure82.3Selling, general and administrative, Q2 FY2026, three months to 2026-07-04$82.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Operating income$m17.6Operating income, Q3 FY2023, three months to 2023-09-30$17.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure24.2Operating income, Q4 FY2023, three months to 2023-12-30$24.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure24.7Operating income, Q1 FY2024, three months to 2024-03-30$24.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure17.8Operating income, Q2 FY2024, three months to 2024-06-29$17.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure15.6Operating income, Q3 FY2024, three months to 2024-09-28$15.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure8.2Operating income, Q4 FY2024, three months to 2024-12-28$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure15.7Operating income, Q1 FY2025, three months to 2025-03-29$15.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure16.7Operating income, Q2 FY2025, three months to 2025-06-28$16.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure1.2Operating income, Q3 FY2025, three months to 2025-09-27$1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure3.8Operating income, Q4 FY2025, three months to 2026-01-03$3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure13.9Operating income, Q1 FY2026, three months to 2026-04-04$13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure(20.0)Operating income, Q2 FY2026, three months to 2026-07-04−$20.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Interest expense$m0.0Interest expense, Q3 FY2023, three months to 2023-09-30$43.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-07, accession 0000896264-23-000030.Report this figure0.1Interest expense, Q4 FY2023, three months to 2023-12-30$145.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-27, accession 0000896264-24-000093. Derived: 12-month figure less the 9-month figure.Report this figure0.1Interest expense, Q1 FY2024, three months to 2024-03-30$52.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-07, accession 0000896264-24-000165.Report this figure0.1Interest expense, Q2 FY2024, three months to 2024-06-29$51.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure0.0Interest expense, Q3 FY2024, three months to 2024-09-28$49.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure0.1Interest expense, Q4 FY2024, three months to 2024-12-28$129.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure0.4Interest expense, Q1 FY2025, three months to 2025-03-29$411.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure0.3Interest expense, Q2 FY2025, three months to 2025-06-28$259.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure0.0Interest expense, Q3 FY2025, three months to 2025-09-27$49.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure0.1Interest expense, Q4 FY2025, three months to 2026-01-03$123.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure0.2Interest expense, Q1 FY2026, three months to 2026-04-04$240.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure0.0Interest expense, Q2 FY2026, three months to 2026-07-04$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Income tax$m9.2Income tax, Q3 FY2023, three months to 2023-09-30$9.2m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure9.8Income tax, Q4 FY2023, three months to 2023-12-30$9.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure10.6Income tax, Q1 FY2024, three months to 2024-03-30$10.6m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure9.8Income tax, Q2 FY2024, three months to 2024-06-29$9.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure8.0Income tax, Q3 FY2024, three months to 2024-09-28$8.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure5.9Income tax, Q4 FY2024, three months to 2024-12-28$5.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure7.4Income tax, Q1 FY2025, three months to 2025-03-29$7.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure8.4Income tax, Q2 FY2025, three months to 2025-06-28$8.4m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure8.5Income tax, Q3 FY2025, three months to 2025-09-27$8.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure5.8Income tax, Q4 FY2025, three months to 2026-01-03$5.8m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure8.5Income tax, Q1 FY2026, three months to 2026-04-04$8.5m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure9.1Income tax, Q2 FY2026, three months to 2026-07-04$9.1m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Net income$m11.3Net income, Q3 FY2023, three months to 2023-09-30$11.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure16.8Net income, Q4 FY2023, three months to 2023-12-30$16.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure16.5Net income, Q1 FY2024, three months to 2024-03-30$16.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure10.4Net income, Q2 FY2024, three months to 2024-06-29$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure10.6Net income, Q3 FY2024, three months to 2024-09-28$10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure4.5Net income, Q4 FY2024, three months to 2024-12-28$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure9.4Net income, Q1 FY2025, three months to 2025-03-29$9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure9.7Net income, Q2 FY2025, three months to 2025-06-28$9.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure(6.5)Net income, Q3 FY2025, three months to 2025-09-27−$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure(1.8)Net income, Q4 FY2025, three months to 2026-01-03−$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure7.5Net income, Q1 FY2026, three months to 2026-04-04$7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure(21.4)Net income, Q2 FY2026, three months to 2026-07-04−$21.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Diluted EPS$ per share0.59Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figurenot reported0.86Diluted EPS, Q1 FY2024, three months to 2024-03-30$0.86 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure0.54Diluted EPS, Q2 FY2024, three months to 2024-06-29$0.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure0.56Diluted EPS, Q3 FY2024, three months to 2024-09-28$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figurenot reported0.49Diluted EPS, Q1 FY2025, three months to 2025-03-29$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure0.52Diluted EPS, Q2 FY2025, three months to 2025-06-28$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure(0.36)Diluted EPS, Q3 FY2025, three months to 2025-09-27−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figurenot reported0.41Diluted EPS, Q1 FY2026, three months to 2026-04-04$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure(1.16)Diluted EPS, Q2 FY2026, three months to 2026-07-04−$1.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Basic EPS$ per share0.59Basic EPS, Q3 FY2023, three months to 2023-09-30$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figurenot reported0.86Basic EPS, Q1 FY2024, three months to 2024-03-30$0.86 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure0.55Basic EPS, Q2 FY2024, three months to 2024-06-29$0.55 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure0.56Basic EPS, Q3 FY2024, three months to 2024-09-28$0.56 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figurenot reported0.49Basic EPS, Q1 FY2025, three months to 2025-03-29$0.49 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure0.52Basic EPS, Q2 FY2025, three months to 2025-06-28$0.52 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure(0.36)Basic EPS, Q3 FY2025, three months to 2025-09-27−$0.36 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figurenot reported0.41Basic EPS, Q1 FY2026, three months to 2026-04-04$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure(1.16)Basic EPS, Q2 FY2026, three months to 2026-07-04−$1.16 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure

Balance sheet

Cash and equivalents$168.6m, Q2 FY2026
Shareholders' equity$526.3m, Q2 FY2026
Usana Health Sciences Inc, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-30Q1 FY20242024-03-30Q2 FY20242024-06-29Q3 FY20242024-09-28FY20242024-12-28Q1 FY20252025-03-29Q2 FY20252025-06-28Q3 FY20252025-09-27FY20252026-01-03Q1 FY20262026-04-04Q2 FY20262026-07-04
Cash and equivalents$m307Cash and equivalents, Q3 FY2023, at 2023-09-30$307.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure330Cash and equivalents, FY2023, at 2023-12-30$330.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure328Cash and equivalents, Q1 FY2024, at 2024-03-30$328.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure332Cash and equivalents, Q2 FY2024, at 2024-06-29$332.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure365Cash and equivalents, Q3 FY2024, at 2024-09-28$364.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure182Cash and equivalents, FY2024, at 2024-12-28$181.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure180Cash and equivalents, Q1 FY2025, at 2025-03-29$179.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure151Cash and equivalents, Q2 FY2025, at 2025-06-28$151.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure145Cash and equivalents, Q3 FY2025, at 2025-09-27$145.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure158Cash and equivalents, FY2025, at 2026-01-03$158.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure163Cash and equivalents, Q1 FY2026, at 2026-04-04$162.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure169Cash and equivalents, Q2 FY2026, at 2026-07-04$168.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Current assets$m390Current assets, Q3 FY2023, at 2023-09-30$390.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0000896264-23-000030.Report this figure418Current assets, FY2023, at 2023-12-30$417.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-12, accession 0000896264-25-000092.Report this figure421Current assets, Q1 FY2024, at 2024-03-30$421.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-07, accession 0000896264-24-000165.Report this figure419Current assets, Q2 FY2024, at 2024-06-29$419.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-06, accession 0000896264-24-000208.Report this figure451Current assets, Q3 FY2024, at 2024-09-28$451.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure279Current assets, FY2024, at 2024-12-28$279.2m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure281Current assets, Q1 FY2025, at 2025-03-29$281.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure262Current assets, Q2 FY2025, at 2025-06-28$261.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure264Current assets, Q3 FY2025, at 2025-09-27$264.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure288Current assets, FY2025, at 2026-01-03$288.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure294Current assets, Q1 FY2026, at 2026-04-04$294.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure281Current assets, Q2 FY2026, at 2026-07-04$281.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Total assets$m601Total assets, Q3 FY2023, at 2023-09-30$601.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0000896264-23-000030.Report this figure633Total assets, FY2023, at 2023-12-30$632.8m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-12, accession 0000896264-25-000092.Report this figure629Total assets, Q1 FY2024, at 2024-03-30$629.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-07, accession 0000896264-24-000165.Report this figure631Total assets, Q2 FY2024, at 2024-06-29$631.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-06, accession 0000896264-24-000208.Report this figure671Total assets, Q3 FY2024, at 2024-09-28$671.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure748Total assets, FY2024, at 2024-12-28$748.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure747Total assets, Q1 FY2025, at 2025-03-29$746.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure735Total assets, Q2 FY2025, at 2025-06-28$734.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure727Total assets, Q3 FY2025, at 2025-09-27$726.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure743Total assets, FY2025, at 2026-01-03$742.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure739Total assets, Q1 FY2026, at 2026-04-04$739.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure703Total assets, Q2 FY2026, at 2026-07-04$703.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Current liabilities$m113Current liabilities, Q3 FY2023, at 2023-09-30$112.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0000896264-23-000030.Report this figure119Current liabilities, FY2023, at 2023-12-30$118.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-12, accession 0000896264-25-000092.Report this figure113Current liabilities, Q1 FY2024, at 2024-03-30$112.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-07, accession 0000896264-24-000165.Report this figure104Current liabilities, Q2 FY2024, at 2024-06-29$103.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-06, accession 0000896264-24-000208.Report this figure115Current liabilities, Q3 FY2024, at 2024-09-28$114.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure140Current liabilities, FY2024, at 2024-12-28$139.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure137Current liabilities, Q1 FY2025, at 2025-03-29$137.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure122Current liabilities, Q2 FY2025, at 2025-06-28$121.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure119Current liabilities, Q3 FY2025, at 2025-09-27$118.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure129Current liabilities, FY2025, at 2026-01-03$128.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure117Current liabilities, Q1 FY2026, at 2026-04-04$117.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure106Current liabilities, Q2 FY2026, at 2026-07-04$105.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Total liabilities$mnot reported136Total liabilities, FY2023, at 2023-12-30$135.6m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-12, accession 0000896264-25-000092.Report this figurenot reportednot reportednot reported162Total liabilities, FY2024, at 2024-12-28$161.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure163Total liabilities, Q1 FY2025, at 2025-03-29$162.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure149Total liabilities, Q2 FY2025, at 2025-06-28$149.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure145Total liabilities, Q3 FY2025, at 2025-09-27$145.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure157Total liabilities, FY2025, at 2026-01-03$156.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure144Total liabilities, Q1 FY2026, at 2026-04-04$144.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure132Total liabilities, Q2 FY2026, at 2026-07-04$132.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Shareholders' equity$m470Shareholders' equity, Q3 FY2023, at 2023-09-30$470.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure497Shareholders' equity, FY2023, at 2023-12-30$497.2m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure500Shareholders' equity, Q1 FY2024, at 2024-03-30$500.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure512Shareholders' equity, Q2 FY2024, at 2024-06-29$512.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure533Shareholders' equity, Q3 FY2024, at 2024-09-28$533.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure532Shareholders' equity, FY2024, at 2024-12-28$532.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure530Shareholders' equity, Q1 FY2025, at 2025-03-29$529.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure531Shareholders' equity, Q2 FY2025, at 2025-06-28$531.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure528Shareholders' equity, Q3 FY2025, at 2025-09-27$528.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure533Shareholders' equity, FY2025, at 2026-01-03$533.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure544Shareholders' equity, Q1 FY2026, at 2026-04-04$543.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure526Shareholders' equity, Q2 FY2026, at 2026-07-04$526.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure

Cash flow

Operating cash flow$23.3m, Q2 FY2026
Capital expenditure$3.2m, Q2 FY2026
Share repurchases$0, Q2 FY2026
Usana Health Sciences Inc, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-30Q1 FY20242024-03-30Q2 FY20242024-06-29Q3 FY20242024-09-28Q4 FY20242024-12-28Q1 FY20252025-03-29Q2 FY20252025-06-28Q3 FY20252025-09-27Q4 FY20252026-01-03Q1 FY20262026-04-04Q2 FY20262026-07-04
Operating cash flow$m22.2Operating cash flow, Q3 FY2023, three months to 2023-09-30$22.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-05, accession 0000896264-24-000222. Derived: 9-month figure less the 6-month figure.Report this figure26.0Operating cash flow, Q4 FY2023, three months to 2023-12-30$26.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure17.7Operating cash flow, Q1 FY2024, three months to 2024-03-30$17.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure8.0Operating cash flow, Q2 FY2024, three months to 2024-06-29$8.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-05, accession 0000896264-25-000205. Derived: 6-month figure less the 3-month figure.Report this figure29.5Operating cash flow, Q3 FY2024, three months to 2024-09-28$29.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0000896264-25-000224. Derived: 9-month figure less the 6-month figure.Report this figure5.8Operating cash flow, Q4 FY2024, three months to 2024-12-28$5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure15.5Operating cash flow, Q1 FY2025, three months to 2025-03-29$15.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure12.2Operating cash flow, Q2 FY2025, three months to 2025-06-28$12.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0000896264-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure(2.0)Operating cash flow, Q3 FY2025, three months to 2025-09-27−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0000896264-25-000224. Derived: 9-month figure less the 6-month figure.Report this figure(3.4)Operating cash flow, Q4 FY2025, three months to 2026-01-03−$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure9.8Operating cash flow, Q1 FY2026, three months to 2026-04-04$9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure23.3Operating cash flow, Q2 FY2026, three months to 2026-07-04$23.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0000896264-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m1.5Capital expenditure, Q3 FY2023, three months to 2023-09-30$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-05, accession 0000896264-24-000222. Derived: 9-month figure less the 6-month figure.Report this figure7.3Capital expenditure, Q4 FY2023, three months to 2023-12-30$7.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure3.2Capital expenditure, Q1 FY2024, three months to 2024-03-30$3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure2.7Capital expenditure, Q2 FY2024, three months to 2024-06-29$2.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-05, accession 0000896264-25-000205. Derived: 6-month figure less the 3-month figure.Report this figure2.4Capital expenditure, Q3 FY2024, three months to 2024-09-28$2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0000896264-25-000224. Derived: 9-month figure less the 6-month figure.Report this figure1.8Capital expenditure, Q4 FY2024, three months to 2024-12-28$1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure2.8Capital expenditure, Q1 FY2025, three months to 2025-03-29$2.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure5.0Capital expenditure, Q2 FY2025, three months to 2025-06-28$5.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0000896264-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure3.2Capital expenditure, Q3 FY2025, three months to 2025-09-27$3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0000896264-25-000224. Derived: 9-month figure less the 6-month figure.Report this figure2.8Capital expenditure, Q4 FY2025, three months to 2026-01-03$2.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure2.6Capital expenditure, Q1 FY2026, three months to 2026-04-04$2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure3.2Capital expenditure, Q2 FY2026, three months to 2026-07-04$3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0000896264-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure
Share repurchases$m11.6Share repurchases, Q3 FY2023, three months to 2023-09-30$11.6m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2024-11-05, accession 0000896264-24-000222. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2023, three months to 2023-12-30$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure9.4Share repurchases, Q1 FY2024, three months to 2024-03-30$9.4m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure0.0Share repurchases, Q2 FY2024, three months to 2024-06-29$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-08-05, accession 0000896264-25-000205. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2024, three months to 2024-09-28$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-05, accession 0000896264-25-000224. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2024, three months to 2024-12-28$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure12.3Share repurchases, Q1 FY2025, three months to 2025-03-29$12.3m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure15.2Share repurchases, Q2 FY2025, three months to 2025-06-28$15.2m. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-13, accession 0000896264-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure0.0Share repurchases, Q3 FY2025, three months to 2025-09-27$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2025-11-05, accession 0000896264-25-000224. Derived: 9-month figure less the 6-month figure.Report this figure0.0Share repurchases, Q4 FY2025, three months to 2026-01-03$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure0.0Share repurchases, Q1 FY2026, three months to 2026-04-04$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure0.0Share repurchases, Q2 FY2026, three months to 2026-07-04$0. XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock. 10-Q filed 2026-08-13, accession 0000896264-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)18.49m, Q2 FY2026
Usana Health Sciences Inc, shares, quarterly
Line itemUnitQ3 FY20222022-10-01Q1 FY20232023-04-01Q2 FY20232023-07-01Q3 FY20232023-09-30Q1 FY20242024-03-30Q2 FY20242024-06-29Q3 FY20242024-09-28Q1 FY20252025-03-29Q2 FY20252025-06-28Q3 FY20252025-09-27Q1 FY20262026-04-04Q2 FY20262026-07-04
Diluted shares (weighted)m shares19.3Diluted shares (weighted), Q3 FY2022, three months to 2022-10-0119,252,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0000896264-23-000030.Report this figure19.3Diluted shares (weighted), Q1 FY2023, three months to 2023-04-0119,328,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-07, accession 0000896264-24-000165.Report this figure19.4Diluted shares (weighted), Q2 FY2023, three months to 2023-07-0119,427,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-06, accession 0000896264-24-000208.Report this figure19.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3019,372,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-05, accession 0000896264-24-000222.Report this figure19.3Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3019,302,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-06, accession 0000896264-25-000126.Report this figure19.2Diluted shares (weighted), Q2 FY2024, three months to 2024-06-2919,159,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-05, accession 0000896264-25-000205.Report this figure19.1Diluted shares (weighted), Q3 FY2024, three months to 2024-09-2819,083,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure19.1Diluted shares (weighted), Q1 FY2025, three months to 2025-03-2919,085,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure18.5Diluted shares (weighted), Q2 FY2025, three months to 2025-06-2818,536,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure18.3Diluted shares (weighted), Q3 FY2025, three months to 2025-09-2718,293,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure18.4Diluted shares (weighted), Q1 FY2026, three months to 2026-04-0418,411,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure18.5Diluted shares (weighted), Q2 FY2026, three months to 2026-07-0418,486,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure

Shares outstanding: 18.48mShares outstanding, period not labelled, at 2026-08-1118,476,534 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. Listed shows no prices and gives no investment advice.